Robert Kristal - Nov 3, 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role: Chief Financial Officer
Signature: /s/ Robert Kristal
Stock symbol: BRTX
Transactions as of: Nov 3, 2022
Transactions value $: $0
Form type: 4
Date filed: 11/4/2022, 04:24 PM
Previous filing: Jun 15, 2022
Next filing: Feb 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BRTX	Common Stock						7.99K	Nov 3, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRTX	Stock Option	Disposed to Issuer	$0	-10.5K	-100%	$0.00^*	0	Nov 3, 2022	Common Stock	10.5K	$13.50	Direct	F1, F2
transaction	BRTX	Stock Option	Award	$0	+10.5K		$0.00	10.5K	Nov 3, 2022	Common Stock	10.5K	$5.08	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
F2	The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with a reduced exercise price.